S C I E N T I F I C   I N N O V A T I O N

Allesh Biosciences Labs brings innovation, as the foremost value-add. We believe, this can be effectively achieved by combining training and research. We train entrepreneurs and our researchers to think “out of the box” and encourage them to enhance creativity at work.

We integrate training and research to innovative, and to explore novel scientific domains like computational chemistry, chemoinformatics, bioinformatics and chemogenomics, with a motive to transform knowledge into value-additions for our economy. Thus we adhere to human inventiveness as the ultimate driver of an economy.

An article entitled "In silico drug discovery: Tools for bridging the NCE gap" that appeared in NATURE BIOTECHNOLOGY, Vol 16, 1998, quotes:
"The infrastructure is now in place for bioinformatics to launch drug discovery on a new growth curve."

The article also quotes: "We point out that a confluence of technological and biological breakthroughs has positioned the pharmaceutical and biotechnology industries for sustained high growth. This new growth curve is based on the central role of informatics. Biotechnology entrepreneurs, corporate entrepreneurs, and venture capitalists committed to these new approaches to information management are transforming the industry. Ultimately though, the success of these initiatives will be measured, not on the allure of the technology, but by their contribution to maintaining industry growth by bringing more and better drugs to the market faster.